Gremese, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 11.373
AS - Asia 8.061
EU - Europa 7.517
SA - Sud America 1.655
AF - Africa 324
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 23
AN - Antartide 2
Totale 28.991
Nazione #
US - Stati Uniti d'America 10.980
SG - Singapore 3.696
CN - Cina 1.793
IT - Italia 1.561
BR - Brasile 1.344
DE - Germania 1.234
SE - Svezia 1.133
FR - Francia 901
VN - Vietnam 738
PL - Polonia 562
IE - Irlanda 415
GB - Regno Unito 388
UA - Ucraina 388
IN - India 343
ID - Indonesia 269
FI - Finlandia 253
HK - Hong Kong 230
CA - Canada 211
RU - Federazione Russa 191
JP - Giappone 183
BD - Bangladesh 163
AR - Argentina 122
TR - Turchia 117
MX - Messico 106
IQ - Iraq 89
NL - Olanda 83
ZA - Sudafrica 83
BE - Belgio 77
ES - Italia 63
AT - Austria 56
KR - Corea 56
SA - Arabia Saudita 55
CI - Costa d'Avorio 52
PK - Pakistan 52
IR - Iran 45
EC - Ecuador 43
VE - Venezuela 43
MA - Marocco 40
CZ - Repubblica Ceca 35
AU - Australia 32
CH - Svizzera 31
CO - Colombia 31
PH - Filippine 29
TN - Tunisia 29
LT - Lituania 26
EG - Egitto 25
KE - Kenya 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
JO - Giordania 20
CL - Cile 19
IL - Israele 19
MY - Malesia 17
PE - Perù 17
DZ - Algeria 16
RO - Romania 16
NP - Nepal 15
CR - Costa Rica 14
PY - Paraguay 14
AZ - Azerbaigian 12
EU - Europa 12
GR - Grecia 12
UY - Uruguay 12
HN - Honduras 11
BO - Bolivia 10
ET - Etiopia 10
JM - Giamaica 10
PT - Portogallo 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
NG - Nigeria 9
AL - Albania 8
EE - Estonia 8
PA - Panama 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
GE - Georgia 7
LV - Lettonia 7
RS - Serbia 7
SN - Senegal 7
AO - Angola 6
BG - Bulgaria 6
KG - Kirghizistan 6
LA - Repubblica Popolare Democratica del Laos 6
MD - Moldavia 6
TH - Thailandia 6
GT - Guatemala 5
HU - Ungheria 5
KH - Cambogia 5
LB - Libano 5
LK - Sri Lanka 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
DO - Repubblica Dominicana 4
GA - Gabon 4
LU - Lussemburgo 4
MM - Myanmar 4
OM - Oman 4
BH - Bahrain 3
Totale 28.917
Città #
Singapore 1.961
Chandler 1.270
Ashburn 1.195
San Jose 983
Warsaw 504
Dublin 390
Beijing 360
New York 333
Rome 297
Los Angeles 264
Ho Chi Minh City 251
Fairfield 244
Jakarta 242
Wilmington 235
Ann Arbor 234
Dearborn 225
Jacksonville 216
Milan 207
Lauterbourg 204
San Mateo 204
Hong Kong 201
The Dalles 197
Woodbridge 193
Hanoi 190
Dallas 186
Houston 184
Nanjing 165
Munich 161
Boston 158
Seattle 158
Chicago 154
Hefei 154
Tokyo 153
Frankfurt am Main 136
Cattolica 126
São Paulo 125
Princeton 112
Moscow 98
Helsinki 97
Bremen 96
Cambridge 85
Marseille 83
Lawrence 77
London 72
Brussels 67
Santa Clara 67
Boardman 66
Buffalo 65
Redwood City 63
St Louis 59
Nuremberg 56
Orem 56
Pune 55
Montreal 53
Abidjan 52
North Bergen 52
Seoul 49
Atlanta 48
Izmir 48
Council Bluffs 46
Nanchang 46
Paris 46
Toronto 43
Rio de Janeiro 42
Denver 41
Norwalk 41
Shanghai 41
Chennai 40
Turku 40
Hangzhou 39
Phoenix 36
Tianjin 36
Johannesburg 35
Da Nang 34
Kent 34
Brooklyn 33
Kunming 33
Redmond 33
Baghdad 32
Guangzhou 32
Haiphong 32
Lappeenranta 32
Amsterdam 31
Hebei 31
Mexico City 31
Lancaster 29
Naples 28
Washington 28
Falls Church 27
Mountain View 27
Shenyang 27
Stockholm 27
San Francisco 26
Curitiba 25
Dhaka 25
Manchester 25
Vienna 25
Brasília 24
Augusta 23
Brno 23
Totale 15.385
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 527
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 494
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 441
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 359
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 349
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 344
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 308
COVID-19 atypical Parsonage-Turner syndrome: a case report 272
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 267
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 262
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 258
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 238
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 236
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 231
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 214
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 214
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 207
Malnutrition in COVID-19 survivors: prevalence and risk factors 204
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 204
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 199
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 199
COVID-19 atypical Parsonage-Turner syndrome: a case report 197
Residual respiratory impairment after COVID-19 pneumonia 196
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 192
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 191
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 189
Adult onset Still's disease and pregnancy 183
Malnutrition in COVID-19 survivors: prevalence and risk factors 182
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 182
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 181
Residual respiratory impairment after COVID-19 pneumonia 177
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 176
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 174
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 174
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 174
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 168
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 166
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 165
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 165
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 164
Sarilumab use in severe SARS-CoV-2 pneumonia 164
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 160
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 158
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 158
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 156
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 156
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 152
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 148
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 147
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 146
Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 145
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
Extension of Lung Damage at Chest Computed Tomography in Severely Ill COVID-19 Patients Treated with Interleukin-6 Receptor Blockers Correlates with Inflammatory Cytokines Production and Prognosis 141
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 141
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 141
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 140
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 138
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 136
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 130
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 130
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 128
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 128
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 128
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 128
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 127
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 126
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 126
Immune-Guided Therapy of COVID-19 126
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 125
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 125
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 125
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 124
Use of First-Line Oral Analgesics during and after COVID-19: Results from a Survey on a Sample of Italian 696 COVID-19 Survivors with Post-Acute Symptoms 124
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 124
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 123
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 122
IL COINVOLGIMENTO ARTICOLARE NEL LES: LA FORMA CLASSICA E LA VARIANTE “RHUPUS” 122
An unusual lung involvement in scleroderma: lipoid pneumonia 122
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 121
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 121
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 121
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 120
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 120
Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review 120
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 118
null 118
Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship? 117
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 116
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 116
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years 116
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 115
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 115
Totale 17.541
Categoria #
all - tutte 129.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.771 198 110 56 104 110 54 40 224 88 127 258 402
2022/20234.037 455 473 356 669 326 510 195 286 448 106 131 82
2023/20242.242 86 549 83 104 92 350 193 90 40 119 295 241
2024/20254.393 104 101 352 175 357 176 184 187 679 451 849 778
2025/202611.426 1.664 385 729 1.337 1.791 640 1.882 536 653 799 383 627
2026/202798 98 0 0 0 0 0 0 0 0 0 0 0
Totale 29.403